John Radford
21PUBLICATIONS
126CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (21)
Sort by Publication Date:
|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker
|Aug 14, 2025
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani
|Jan 08, 2025
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.Elizabeth H Phillips, Nicholas Counsell, Tim Illidge
|Mar 13, 2024
Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers.John Radford
|Oct 26, 2023
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.Stefano Luminari, Alexander Fossa, Judith Trotman
|Oct 23, 2023
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial.Mehdi Hamadani, Alexander Spira, Xiaolei Zhou
Pageof 4
Frequent Collaborators
5 joint publications
Pier Luigi Zinzani
5 joint publications
Mehdi Hamadani
4 joint publications
Carmelo Carlo-Stella
4 joint publications
Brad S Kahl
3 joint publications
Alex F Herrera
3 joint publications
Juan Pablo Alderuccio
3 joint publications
Paolo F Caimi
3 joint publications
Sally F Barrington
2 joint publications
Stefano A Pileri
2 joint publications
Pamela McKay
